Dr Eva Szigethy and colleagues from Pennsylvania, USA determined the utility of including neurovegetative symptoms in assessments of depression in youth with inflammatory bowel disease.
The team enrolled 41 youth with inflammatory bowel disease and concurrent depressive symptomatology in an intervention trial and received either 9 modules of cognitive-behavioral therapy (PASCET-PI) or treatment as usual.
Youth and their primary caregivers completed the Children's Depression Inventory at pre- and posttreatment.
Disease severity measures and current steroid dosage were obtained at each timepoint.
Change in the individual items of the Children's Depression Inventory was compared across groups and examined in association with change in physical illness course.
The researchers used paired sample t-tests to reveal changes in the Children's Depression Inventory item scores from pre- and posttreatment for a majority of the depressive symptoms assessed in the PASCET-PI.
|Somatic symptoms seem to respond to psychotherapeutic intervention|
|Inflammatory Bowel Diseases |
These changes did not appear to be linked to changes in disease severity and/or steroid dosage across these same timepoints.
Dr Szigethy’s team concluded, “The inclusion of somatic items in the assessment of depression in physically ill youth is important, as these symptoms seem to respond to psychotherapeutic intervention.”
“The present results would suggest that improvements in depressive symptomatology are not solely related to improvements in the course of inflammatory bowel disease.”
“These items do reflect an important part of the profile of depressive symptoms in youth with inflammatory bowel disease.”
“Future research is warranted to replicate present findings and explore the generalizability of these results to other pediatric illness populations.”